Literature DB >> 19592666

Endocannabinoids suppress excitatory synaptic transmission to dorsal raphe serotonin neurons through the activation of presynaptic CB1 receptors.

Samir Haj-Dahmane1, Roh-Yu Shen.   

Abstract

Endocannabinoid signaling in the dorsal raphe (DR) has recently been implicated in the regulation of anxiety and depression. However, the cellular mechanisms by which endocannabinoids (eCBs) regulate the excitability of DR 5-hydroxytryptamine (serotonin; 5-HT) neurons remain poorly understood. In the present study, using whole-cell recording from DR 5-HT neurons, we examined the effects of eCBs on glutamatergic synapses in the DR. We found that the eCB anandamide decreased the amplitude of evoked excitatory postsynaptic currents (eEPSCs). This effect was blocked by CB(1) receptor antagonist N-(piperidin-1-yl)-5-(4-iodophenyl)-4-methyl-1H-pyrazole-3-carboxamide (AM 251) and mimicked by (R)-(+)-[2,3-dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphthalenylmethanone mesylate (WIN 55,212-2), a CB(1) receptor agonist. The inhibition of eEPSC amplitude was associated with an increase in the paired-pulse ratio and coefficient of variance. Activation of CB(1) receptors also reduced the frequency, but not the amplitude, of miniature excitatory postsynaptic currents, indicating that eCBs inhibit glutamate release in the DR. In addition, we found that depolarization of DR 5-HT neurons induced a transient inhibition of the amplitude of eEPSCs, termed depolarization-induced suppression of excitation (DSE). The induction of DSE required an increase in postsynaptic intracellular calcium and was due to a decrease in glutamate release. Furthermore, pharmacological studies showed that blockade of CB(1) receptors with AM 251 abolished the DSE. In contrast, activation of CB(1) receptors with WIN 55,212-2 mimicked and occluded the DSE, indicating that depolarization of DR 5-HT neurons triggers eCB release, which in turn mediates the DSE. Together, these results indicate that eCBs play a role in modulating glutamatergic synaptic transmission to DR 5-HT neurons.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19592666      PMCID: PMC2766225          DOI: 10.1124/jpet.109.153858

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  56 in total

1.  CB1 cannabinoid receptors mediate anxiolytic effects: convergent genetic and pharmacological evidence with CB1-specific agents.

Authors:  J Haller; B Varga; C Ledent; T F Freund
Journal:  Behav Pharmacol       Date:  2004-07       Impact factor: 2.293

2.  Involvement of 5-HT1A receptors in behavioural effects of the cannabinoid receptor agonist CP 55,940 in male rats.

Authors:  E M Marco; L Pérez-Alvarez; E Borcel; M Rubio; C Guaza; E Ambrosio; S E File; M P Viveros
Journal:  Behav Pharmacol       Date:  2004-02       Impact factor: 2.293

3.  Intracellular recordings from serotonergic dorsal raphe neurons: pacemaker potentials and the effect of LSD.

Authors:  G K Aghajanian; C P Vandermaelen
Journal:  Brain Res       Date:  1982-04-29       Impact factor: 3.252

4.  Presynaptic cannabinoid sensitivity is a major determinant of depolarization-induced retrograde suppression at hippocampal synapses.

Authors:  Takako Ohno-Shosaku; Hiroshi Tsubokawa; Ichiro Mizushima; Norihide Yoneda; Andreas Zimmer; Masanobu Kano
Journal:  J Neurosci       Date:  2002-05-15       Impact factor: 6.167

5.  Structure of a cannabinoid receptor and functional expression of the cloned cDNA.

Authors:  L A Matsuda; S J Lolait; M J Brownstein; A C Young; T I Bonner
Journal:  Nature       Date:  1990-08-09       Impact factor: 49.962

6.  GABA- and glutamate-mediated synaptic potentials in rat dorsal raphe neurons in vitro.

Authors:  Z Z Pan; J T Williams
Journal:  J Neurophysiol       Date:  1989-04       Impact factor: 2.714

7.  Unconditioned and conditioned anxiogenic effects of the cannabinoid receptor agonist CP 55,940 in the social interaction test.

Authors:  Rachel F Genn; Sonia Tucci; Eva M Marco; M Paz Viveros; Sandra E File
Journal:  Pharmacol Biochem Behav       Date:  2004-03       Impact factor: 3.533

8.  Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors.

Authors:  Miriam Melis; Marco Pistis; Simona Perra; Anna Lisa Muntoni; Giuliano Pillolla; Gian Luigi Gessa
Journal:  J Neurosci       Date:  2004-01-07       Impact factor: 6.167

9.  Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study.

Authors:  M Herkenham; A B Lynn; M R Johnson; L S Melvin; B R de Costa; K C Rice
Journal:  J Neurosci       Date:  1991-02       Impact factor: 6.167

10.  Retrograde activation of presynaptic NMDA receptors enhances GABA release at cerebellar interneuron-Purkinje cell synapses.

Authors:  Ian C Duguid; Trevor G Smart
Journal:  Nat Neurosci       Date:  2004-04-18       Impact factor: 24.884

View more
  32 in total

1.  Endocannabinoids in the brainstem modulate dural trigeminovascular nociceptive traffic via CB1 and "triptan" receptors: implications in migraine.

Authors:  Simon Akerman; Philip R Holland; Michele P Lasalandra; Peter J Goadsby
Journal:  J Neurosci       Date:  2013-09-11       Impact factor: 6.167

2.  Brain serotonergic circuitries.

Authors:  Yves Charnay; Lucienne Léger
Journal:  Dialogues Clin Neurosci       Date:  2010       Impact factor: 5.986

3.  Endocannabinoids mediate the glucocorticoid-induced inhibition of excitatory synaptic transmission to dorsal raphe serotonin neurons.

Authors:  Jue Wang; Roh-Yu Shen; Samir Haj-Dahmane
Journal:  J Physiol       Date:  2012-09-03       Impact factor: 5.182

Review 4.  Anandamide and 2-arachidonoylglycerol: pharmacological properties, functional features, and emerging specificities of the two major endocannabinoids.

Authors:  Antonio Luchicchi; Marco Pistis
Journal:  Mol Neurobiol       Date:  2012-07-17       Impact factor: 5.590

5.  Target-specific modulation of the descending prefrontal cortex inputs to the dorsal raphe nucleus by cannabinoids.

Authors:  Sean D Geddes; Saleha Assadzada; David Lemelin; Alexandra Sokolovski; Richard Bergeron; Samir Haj-Dahmane; Jean-Claude Béïque
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-25       Impact factor: 11.205

6.  Genetic deletion of fatty acid amide hydrolase alters emotional behavior and serotonergic transmission in the dorsal raphe, prefrontal cortex, and hippocampus.

Authors:  Francis Rodriguez Bambico; Tommaso Cassano; Sergio Dominguez-Lopez; Noam Katz; Claire Dominique Walker; Daniele Piomelli; Gabriella Gobbi
Journal:  Neuropsychopharmacology       Date:  2010-06-23       Impact factor: 7.853

7.  Presynaptic CB(1) cannabinoid receptors control frontocortical serotonin and glutamate release--species differences.

Authors:  Samira G Ferreira; Filipe M Teixeira; Pedro Garção; Paula Agostinho; Catherine Ledent; Luísa Cortes; Ken Mackie; Attila Köfalvi
Journal:  Neurochem Int       Date:  2012-05-17       Impact factor: 3.921

8.  Endocannabinoids blunt the augmentation of synaptic transmission by serotonin 2A receptors in the nucleus tractus solitarii (nTS).

Authors:  James R Austgen; David D Kline
Journal:  Brain Res       Date:  2013-09-13       Impact factor: 3.252

Review 9.  Drug discovery strategies that focus on the endocannabinoid signaling system in psychiatric disease.

Authors:  Ryan Wyrofsky; Paul McGonigle; Elisabeth J Van Bockstaele
Journal:  Expert Opin Drug Discov       Date:  2014-12-09       Impact factor: 6.098

10.  Anti-migraine effect of ∆9-tetrahydrocannabinol in the female rat.

Authors:  Ram Kandasamy; Cole T Dawson; Rebecca M Craft; Michael M Morgan
Journal:  Eur J Pharmacol       Date:  2017-10-28       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.